Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $18.01 billion. The enterprise value is $18.65 billion.
| Market Cap | 18.01B |
| Enterprise Value | 18.65B |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 234.73 million shares outstanding. The number of shares has decreased by -3.64% in one year.
| Shares Outstanding | 234.73M |
| Shares Change (YoY) | -3.64% |
| Shares Change (QoQ) | -2.80% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 99.69% |
| Float | 232.66M |
Valuation Ratios
The trailing PE ratio is 36.53 and the forward PE ratio is 18.28. Hologic's PEG ratio is 1.45.
| PE Ratio | 36.53 |
| Forward PE | 18.28 |
| PS Ratio | 4.54 |
| Forward PS | 4.33 |
| PB Ratio | 3.87 |
| P/FCF Ratio | 20.97 |
| PEG Ratio | 1.45 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.54, with an EV/FCF ratio of 21.72.
| EV / Earnings | 36.21 |
| EV / Sales | 4.70 |
| EV / EBITDA | 17.54 |
| EV / EBIT | 25.30 |
| EV / FCF | 21.72 |
Financial Position
The company has a current ratio of 3.89, with a Debt / Equity ratio of 0.55.
| Current Ratio | 3.89 |
| Quick Ratio | 2.90 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 2.42 |
| Debt / FCF | 3.00 |
| Interest Coverage | 6.76 |
Financial Efficiency
Return on equity (ROE) is 10.20% and return on invested capital (ROIC) is 6.70%.
| Return on Equity (ROE) | 10.20% |
| Return on Assets (ROA) | 5.70% |
| Return on Capital (ROIC) | 6.70% |
| Revenue Per Employee | $567,854 |
| Profits Per Employee | $73,691 |
| Employee Count | 6,990 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.97 |
Taxes
In the past 12 months, Hologic has paid $113.20 million in taxes.
| Income Tax | 113.20M |
| Effective Tax Rate | 18.02% |
Stock Price Statistics
The stock price has decreased by -10.41% in the last 52 weeks. The beta is 1.02, so Hologic's price volatility has been similar to the market average.
| Beta (1Y) | 1.02 |
| 52-Week Price Change | -10.41% |
| 50-Day Moving Average | 75.84 |
| 200-Day Moving Average | 73.37 |
| Relative Strength Index (RSI) | 52.11 |
| Average Volume (30 Days) | 1,801,832 |
Short Selling Information
The latest short interest is 4.44 million, so 1.89% of the outstanding shares have been sold short.
| Short Interest | 4.44M |
| Short Previous Month | 4.65M |
| Short % of Shares Out | 1.89% |
| Short % of Float | 1.91% |
| Short Ratio (days to cover) | 2.52 |
Income Statement
In the last 12 months, Hologic had revenue of $3.97 billion and earned $515.10 million in profits. Earnings per share was $2.10.
| Revenue | 3.97B |
| Gross Profit | 2.02B |
| Operating Income | 591.00M |
| Pretax Income | 628.30M |
| Net Income | 515.10M |
| EBITDA | 1.06B |
| EBIT | 737.30M |
| Earnings Per Share (EPS) | $2.10 |
Balance Sheet
The company has $1.93 billion in cash and $2.58 billion in debt, giving a net cash position of -$645.90 million or -$2.75 per share.
| Cash & Cash Equivalents | 1.93B |
| Total Debt | 2.58B |
| Net Cash | -645.90M |
| Net Cash Per Share | -$2.75 |
| Equity / Book Value | 4.65B |
| Book Value Per Share | 19.83 |
| Working Capital | 2.60B |
Cash Flow
In the last 12 months, operating cash flow was $1.02 billion and capital expenditures -$159.10 million, giving a free cash flow of $858.70 million.
| Operating Cash Flow | 1.02B |
| Capital Expenditures | -159.10M |
| Free Cash Flow | 858.70M |
| FCF Per Share | $3.60 |
Margins
Gross margin is 50.92%, with operating and profit margins of 14.89% and 12.98%.
| Gross Margin | 50.92% |
| Operating Margin | 14.89% |
| Pretax Margin | 15.83% |
| Profit Margin | 12.98% |
| EBITDA Margin | 26.79% |
| EBIT Margin | 18.58% |
| FCF Margin | 21.63% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.64% |
| Shareholder Yield | 3.64% |
| Earnings Yield | 2.86% |
| FCF Yield | 4.77% |
Analyst Forecast
The average price target for Hologic is $86.82, which is 13.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $86.82 |
| Price Target Difference | 13.18% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 5.56% |
| EPS Growth Forecast (5Y) | 27.94% |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Hologic has an Altman Z-Score of 4.34 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.34 |
| Piotroski F-Score | 6 |